Alone in the spotlight, Pfizer CEO Bourla swears pure intentions in the rush to develop a Covid-19 vaccine. But will the public believe it?
Now that Moderna has shifted expectations on pivotal data for its Covid-19 vaccine to some time just after the election and AstraZeneca has been stalled by a safety issue, the sole player that can deliver a shot through an emergency use authorization this month is Pfizer.
And Pfizer CEO Albert Bourla wants no part of the political furor that has swelled around that topic.
In an open letter, Bourla lamented the spotlight that President Trump directed at Pfizer during the first chaotic presidential debate. Trump — who has just tested positive for the coronavirus, pushing the pandemic back into the headlines — is shoving Pfizer into gale force political winds by insisting that a vaccine could be OK’d in the next few weeks. And the CEO insists that politics has nothing to do with the crash R&D project Pfizer has mounted with BioNTech to get an mRNA jab onto the market as soon as possible.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters